Pinduoduo Launched U.S. e-Commerce Site on Thursday

-Nikkei https://asia.nikkei.com/Business/China-tech/China-s-Pinduoduo-launches-U.S.-e-commerce-site-in-first-foreign-push

byCharles Gross

September 2, 2022

1 minute read

-Nikkei

https://asia.nikkei.com/Business/China-tech/China-s-Pinduoduo-launches-U.S.-e-commerce-site-in-first-foreign-push

Stephens & Co. Maintains Overweight on First Mid Bancshares, Lowers Price Target to $42

By Benzinga Newsdesk

Today, 2:44 AM

Stephens & Co. analyst Terry McEvoy maintains First Mid Bancshares (NASDAQ:FMBH) with a Overweight and lowers the price target from $44 to $42.

FMBH

Meta Analyst Estimates Potential Cost Savings From Fresh Round Of Layoffs, Mostly from Metaverse

By Anusuya Lahiri

Today, 2:44 AM

Mizuho analyst James Lee reiterated Buy on Meta Platforms Inc (NASDAQ:META) with a $210 price target. Several major news outlets indicated that…

InspireMD Announces The Inclusion Of Its CGuard Carotid Stent In CREST-2 Trial Following FDA Approval Of The Investigational Device Exemption Supplement Application

By Benzinga Newsdesk

Today, 2:44 AM

InspireMD, Inc. (NASDAQ:NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, today announced its CGuard Carotid

NSPR

Bone Health Focused Radius Health Goes Private In $890M Deal

By Vandana Singh

Today, 2:44 AM

Radius Health Inc (NASDAQ:RDUS) will be acquired by Gurnet Point Capital and Patient Square Capital in a transaction valued at…

RDUS

Pinduoduo Launched U.S. e-Commerce Site on Thursday

Related Posts

Stephens & Co. Maintains Overweight on First Mid Bancshares, Lowers Price Target to $42

Meta Analyst Estimates Potential Cost Savings From Fresh Round Of Layoffs, Mostly from Metaverse

InspireMD Announces The Inclusion Of Its CGuard Carotid Stent In CREST-2 Trial Following FDA Approval Of The Investigational Device Exemption Supplement Application

Bone Health Focused Radius Health Goes Private In $890M Deal